Increasing molecular diagnostic capacity and COVID-19 incidence in Brazil

Different countries have adopted strategies for the early detection of SARS-CoV-2 since the declaration of community transmission by the World Health Organization (WHO) and timely diagnosis has been considered one of the major obstacles for surveillance and healthcare. Here, we report the increase of the number of laboratories to COVID-19 diagnosis in Brazil. Our results demonstrate an increase and decentralisation of certified laboratories, which does not match the much higher increase in the number of COVID-19 cases. Also, it becomes clear that laboratories are irregularly distributed over the country, with a concentration in the most developed state, São Paulo.

Medienart:

E-Artikel

Erscheinungsjahr:

2020

Erschienen:

2020

Enthalten in:

Zur Gesamtaufnahme - volume:148

Enthalten in:

Epidemiology and infection - 148(2020) vom: 18. Aug., Seite e178

Sprache:

Englisch

Beteiligte Personen:

Grotto, Rejane Maria Tommasini [VerfasserIn]
Santos Lima, Rodrigo [VerfasserIn]
de Almeida, Gabriel Berg [VerfasserIn]
Ferreira, Claudia Pio [VerfasserIn]
Guimarães, Raul Borges [VerfasserIn]
Pronunciate, Micheli [VerfasserIn]
Azevedo, Edmur [VerfasserIn]
Catão, Rafael de Castro [VerfasserIn]
Fortaleza, Carlos Magno Castelo Branco [VerfasserIn]

Links:

Volltext

Themen:

COVID-19
Diagnosis
Epidemiology
Infectious disease
Journal Article
Laboratory tests

Anmerkungen:

Date Completed 14.09.2020

Date Revised 18.12.2020

published: Electronic

Citation Status MEDLINE

doi:

10.1017/S0950268820001818

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM31381807X